| NCT01205659 |
Allergy and Ashthma in Children Who Were Fed Supplemented Infant Formula |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205633 |
Multi-center Registry for CCSVI Testing and Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205620 |
IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205594 |
IRB-HSR# 14296 The Use of the Intrathoracic Pressure Regulator (ITPR) to Improve Systemic Blood Pressure in Patient Undergoing CABG Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205568 |
Cutting Balloon Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205503 |
Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205451 |
A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205412 |
An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205360 |
Dosing Strategies for Automated Mandatory Intermittent Boluses Technique for Epidural Labour Analgesia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205334 |
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205295 |
Patient Anxiety and Concern as Predictors for the Perceived Quality and Efficacy of Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205269 |
The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205256 |
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205204 |
Comparison of Different Doses of Clonidine to Fentanyl as an Adjuvant to Bupivacaine 0.5% for Spinal Anesthesia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205061 |
Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01205035 |
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204957 |
Brown Seaweed as a Breast Cancer Preventive |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204918 |
Efficacy and Tolerability of Riluzole in Treatment Resistant Depression |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204905 |
R5 Integrase Study in HIV-1 Naive Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204892 |
Pain After Laparoscopic Cholecystectomy With Bilateral Tranversus Abdominis Plane (TAP) Block Versus Local Anesthetic Infiltration |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204866 |
Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204658 |
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204632 |
Cardiometabolic Risk, Obesity and Cardiovascular Disease in People With Spinal Cord Injury |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204593 |
baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204567 |
The Influence of Exercise on Mental Health After Discharge From Hospital |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204502 |
Suicide Gene Therapy Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204450 |
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204359 |
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204333 |
Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204320 |
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204294 |
Comprehensive Add on Study in Japan |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204268 |
The Neuroprotection of Sevoflurane Preconditioning on Intracranial Aneurysm Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204203 |
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204151 |
Teaching Math Skills to Individuals With Fragile X Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204060 |
Effect of Allergen Challenge on Inflammation Induced by Toll-like Receptor Stimulation in a Nasal Model |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01204034 |
Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203995 |
Remote Information Counseling for Elders |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203969 |
Safety and Efficacy of Single Port Laparoscopic Surgery in Colon Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203956 |
DeVilbiss AutoAdjust With SmartFlex Comparative Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203904 |
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203761 |
The Experience of Loneliness Among Patients During the Perioperative Period |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203735 |
Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203657 |
UCLA Tai Chi in a Community Setting Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203618 |
Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203605 |
European Surgical Outcomes Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203592 |
Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203566 |
A Randomised Controlled Trial on LESS Versus Conventional Laparoscopic Appendicectomy. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203358 |
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203332 |
Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203293 |
Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203267 |
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203202 |
Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203150 |
Effects of Exercise in People With Paraplegia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203033 |
Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01203020 |
Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202994 |
Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202968 |
Effect of Pre-emptive Transcutaneous Neuro-muscular Electrical Stimulation for Dysphagia in Long Term Intubated Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202903 |
Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202851 |
Relaxation for Women With Breast Cancer Undergoing Radiotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202760 |
A Rheumatoid Arthritis Study in Participants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202734 |
A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202695 |
Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202669 |
Heart Rate Changes in Subjects With Epilepsy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202656 |
Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202604 |
A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202461 |
Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202435 |
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202357 |
Optimal Duration of Early Intervention for Psychosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202318 |
Comparative Evaluation of Stroke Triage Algorithms for Emergency Medical Dispatchers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202305 |
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202292 |
Group Motivational Intervention in Overweight/Obese Patients. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202266 |
A Multiple Dose Study Of PF-05161704 In Healthy Volunteers |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202227 |
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202058 |
An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202032 |
Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01202006 |
Strategy to Recognize and Initiate Treatment of Chronic Heart Failure |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201993 |
Clinical and Laboratory Characteristics of Patients Admitted With Syncope; Diagnosis and Follow up After These Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201967 |
A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201902 |
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201850 |
The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201759 |
Effects of Salsalate on Prandial-Induced Vascular Inflammation After Spinal Cord Injury (SCI) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201733 |
Traditional Thai Massage and Brain Electrical Activity |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201720 |
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure" |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201694 |
Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201668 |
DPBRN Persistent Pain and Root Canal Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201603 |
The Effects of Orange Juice on Insulin Sensitivity and Plasma Lipids |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201551 |
Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201512 |
CONDOR Temporomandibular Muscle and Joint Disorders (TMJD) Survey |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201460 |
DPBRN Blood Sugar Testing in Dental Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201434 |
Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201395 |
DPBRN Longitudinal Study of Repaired or Replaced Dental Restorations |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201369 |
A Study to Examine the Implantation Characteristics of Two Drug-Eluting Stents |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201356 |
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201304 |
Comparison of Methods for the Delivery of Interoceptive Exposure |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201200 |
Right Ventricular Function in Patients With Obstructive Sleep Apnea |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201161 |
Ranibizumab for Diabetic Traction Retinal Detachment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201135 |
GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201057 |
Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201018 |
Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01201005 |
B Vitamin Status in Premature and Small for Gestational Age(SGA) Infants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200992 |
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200966 |
Ethanol Response in Essential Tremor: Clinical and Neurophysiological Correlates |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200758 |
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200732 |
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200693 |
Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200667 |
uPHI: Wireless Body Area Network Core Technology |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200602 |
Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200550 |
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200459 |
SMART: A Social and Mobile Weight Control Program for Young Adults |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200433 |
The Effects of Dexmedetomidine and Propofol on Cerebral Blood Flow and Brain Oxygenation During Deep Brain Stimulation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200420 |
Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200394 |
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200368 |
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200303 |
Evaluation of Computer-assisted, Non-cathartic CT Colonography |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200251 |
Study of Bimatoprost Gel on Eyelash Growth |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200160 |
Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200134 |
HYPONCO - Hypoxia in Brain Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200108 |
AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200095 |
Posterior Cruciate Ligament Reconstruction Using Knot/Press-fit Technique |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200069 |
IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200056 |
Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01200004 |
Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199861 |
Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199835 |
The Effects of Dairy Products on Energy Balance |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199757 |
A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199718 |
Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199705 |
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199692 |
Characterization of Metabolic Biomarkers in Varying Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199666 |
Text Message Reminder-Recalls For Early Childhood Vaccination |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199627 |
Tranexamic Acid Versus Placebo for the Reduction of Blood Loss in Total Hip Replacement Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199458 |
The Effect of an Opioid on the Lower Esophageal Sphincter During Anesthesia Induction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199432 |
Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199406 |
Pain Reduction After Cholecystectomy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199393 |
Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199367 |
Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199302 |
Long-term Safety Study of Brodalumab in Adults With Crohn's Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199250 |
Biomarkers in Samples From Patients With Endometrial Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199159 |
Preoperative Misoprostol in Reducing Blood Loss in Total Abdominal Hysterectomy (TAH) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199133 |
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199120 |
Cognitive Effects of Omega-3 Supplements in Children With Mild to Moderate Malnutrition |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199094 |
Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01199068 |
CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198912 |
Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198860 |
Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis B |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198834 |
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198795 |
Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198769 |
Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198756 |
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198704 |
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198600 |
Ocular Comfort and the "Aging" Lens (ERBIUM) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198561 |
Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of Depression |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198535 |
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198457 |
Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198418 |
A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198405 |
Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198392 |
Trial of S-1 Plus Cisplatin in Gastric Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198366 |
Study of AERAS-402 in Healthy Infants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198158 |
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198132 |
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198093 |
Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198067 |
Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01198002 |
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197950 |
Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197859 |
Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197833 |
Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible Varicosities |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197820 |
Hepatic and Renal Thermography Using Magnetic Resonance Imaging |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197794 |
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197768 |
A Multi-Component Behavioral Nutrition Intervention for Homebound Elderly |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197703 |
European Cardio Computer Tomography Registry |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197651 |
Aortic-Stent-Register |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197612 |
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197560 |
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197534 |
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding. |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197495 |
Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197469 |
Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension? |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197456 |
Predictors of Ovarian Insufficiency in Young Breast Cancer Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197404 |
Affect Management for Early Adolescents |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197261 |
OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197235 |
Effect of Darbepoetin in Contrast-induced Nephropathy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197157 |
Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197118 |
Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197105 |
Evaluation Study of a Mouthwash Based on Schinus Terebinthifolius to Treat Gingivitis in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197092 |
The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01197066 |
Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196858 |
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196832 |
Role of Fibrocytes in Chronic Obstructive Pulmonary Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196793 |
Hospital Admissions in Children Aged 3 Months to 5 Years Presenting With Fever to the Emergency Department |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196767 |
Ropivacaine Though Laterosternal Catheters After Cardiac Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196702 |
Lymphocyte Immunophenotyping in Common Variable Immunodeficiency |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196650 |
Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196559 |
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196533 |
A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196520 |
Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196494 |
Study of Intraoperative Colonic Irrigation Versus Stent Placement in Obstructive Left-Sided Colonic Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196468 |
HIV Indicator Diseases Survey Across Europe - UK Arm |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196403 |
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196351 |
Activity at Ventilation Threshold on Appetite and Food Intake in Boys |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196260 |
Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196234 |
Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
| NCT01196195 |
KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18) |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|